MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

L-Dopa responsiveness in early Parkinson’s disease: Results from the United Kingdom Tracking Parkinson’s study

N. Malek, S. Kanavou, M. Lawton, K. Grosset, V. Pitz, N. Bajaj, R. Barker, D. Burn, T. Foltynie, J. Hardy, N. Wood, N. Williams, H. Morris, Y. Ben-Shlomo, D. Grosset (Ipswich, United Kingdom)

Meeting: 2018 International Congress

Abstract Number: 368

Keywords: Levodopa(L-dopa)

Session Information

Date: Saturday, October 6, 2018

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: We wanted to evaluate L-dopa responsiveness in a large cohort of patients with recently diagnosed Parkinson’s disease (PD) using an acute L-dopa challenge test.

Background: L-dopa responsiveness in PD varies, but the determinants of this response are not clearly defined.

Methods: Patients were assessed using the MDS Unified PD Rating Scale motor scale (UPDRS 3), before and after their usual morning L-dopa dose (after overnight omission of their anti-parkinsonian medication). UPDRS components were standardised to a maximum score of 4 for each, to allow for differing numbers of questions. L-dopa response was rated as excellent (≥30% improvement in UPDRS 3 scores) or moderate (<30% improvement in UPDRS 3 scores).

Results: 1008 cases aged 67.4 years (SD 9.1 years) at diagnosis were tested on average 3.3 years (SD 0.9) into their illness. Each of bradykinesia, rigidity and tremor improved significantly after L-dopa (all p<0.001), though the improvement was significantly greater for bradykinesia at 0.35 points, and rigidity at 0.34 points, than for tremor at 0.19 points (both p<0.001). Similarly, lateralised features improved significantly more (0.31 points) compared to axial features (0.12 points, p<0.001). The overall L-dopa response was 30% in 516 cases (51.2%), in whom the mean reduction in UPDRS 3 was 48.4% (SD 14.1), and was <30% in 492 cases (48.8%) whose mean reduction in UPDRS 3 was 12.7% (SD 14.0). Those showing an excellent response were younger (65.9 years, SD 9.4) than those who demonstrated a moderate response (69.0 years, SD 8.4, p<0.001). The baseline UPDRS 3 scores of those showing an excellent L-dopa response (20.6, SD 10.2) were significantly lower than those demonstrating a moderate response (24.4, SD 13.1, p<0.001). The increase in UPDRS 3 score over the preceding 18 months was less in those showing an excellent response at 2.7 (SD 10.7), compared to those demonstrating a moderate response (5.9, SD 10.5, p<0.001).

Conclusions: The response to L-dopa in early PD shows great variation. The magnitude of change is significantly greater for bradykinesia and rigidity than for tremor, and for lateralised (limb) components compared to axial features. The overall motor response is significantly less in older patients. Suboptimal responses are associated with worse baseline motor scores, and faster motor progression rates. Further exploration of the reasons for these observations is needed.

To cite this abstract in AMA style:

N. Malek, S. Kanavou, M. Lawton, K. Grosset, V. Pitz, N. Bajaj, R. Barker, D. Burn, T. Foltynie, J. Hardy, N. Wood, N. Williams, H. Morris, Y. Ben-Shlomo, D. Grosset. L-Dopa responsiveness in early Parkinson’s disease: Results from the United Kingdom Tracking Parkinson’s study [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/l-dopa-responsiveness-in-early-parkinsons-disease-results-from-the-united-kingdom-tracking-parkinsons-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/l-dopa-responsiveness-in-early-parkinsons-disease-results-from-the-united-kingdom-tracking-parkinsons-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley